Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir


Papatheodoridis G. V. , Dalekos G. N. , Yurdaydin C., Buti M., Goulis J., Arends P., ...Daha Fazla

JOURNAL OF HEPATOLOGY, cilt.62, ss.363-370, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 62 Konu: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.jhep.2014.08.045
  • Dergi Adı: JOURNAL OF HEPATOLOGY
  • Sayfa Sayıları: ss.363-370

Özet

Background & Aims: The risk of hepatocellular carcinoma (HCC) in Caucasian patients with chronic hepatitis B (CHB), treated with entecavir (ETV) or tenofovir (TDF), is unclear. We evaluated the incidence and predictors of HCC and the accuracy of existing HCC risk scores in Caucasian CHB patients receiving ETV/TDF.